Literature DB >> 10188735

Establishment of a human hemangiosarcoma cell line (ISO-HAS).

M Masuzawa1, T Fujimura, Y Hamada, Y Fujita, H Hara, S Nishiyama, K Katsuoka, H Tamauchi, Y Sakurai.   

Abstract

A cell line (ISO-HAS) has been established from tumor tissue of a human hemangiosarcoma arising on the scalp by the use of conditioned medium from a murine-phenotypic angiosarcoma cell line (ISOS-1). Cells have been cultured for more than 2 years with up to 100 passages. The cells retained endothelial-cell properties, such as a characteristic cobblestone appearance at confluency, contact-inhibited growth, active uptake of acetylated low-density lipoprotein labeled with 1,1-dioctadecyl 1,3,3,3,3-tetramethyl-indocarbocyanine perchlorate (DiI-Ac-LDL) and CD31 expression. However, they were weakly positive for von-Willebrand-factor (vWf) antigen and for binding of Ulex europaeus agglutinin-I (UEA-I) lectin, and lacked tube-formation activity. These findings indicate that ISO-HAS is a poorly differentiated endothelial cell line. ISO-HAS cells showed accumulation of p53 protein in the nuclei, and a new-typed p53-gene point mutation was found in exon 7 at codon 240. When inoculated s.c. into severe-combined-immunodeficiency (SCID) mice, the cells showed solid-tumor growth that caused death. These properties suggest that ISO-HAS is a malignant endothelial cell line with high tumorigenicity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10188735     DOI: 10.1002/(sici)1097-0215(19990412)81:2<305::aid-ijc22>3.0.co;2-z

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  23 in total

Review 1.  In vitro models for the evaluation of angiogenic potential in bone engineering.

Authors:  Elisabetta Cenni; Francesca Perut; Nicola Baldini
Journal:  Acta Pharmacol Sin       Date:  2010-11-01       Impact factor: 6.150

2.  Infiltration of PD-1-positive cells in combination with tumor site PD-L1 expression is a positive prognostic factor in cutaneous angiosarcoma.

Authors:  Yuki Honda; Atsushi Otsuka; Sachiko Ono; Yosuke Yamamoto; Judith A Seidel; Satoshi Morita; Masahiro Hirata; Tatsuki R Kataoka; Tatsuya Takenouchi; Kazuyasu Fujii; Takuro Kanekura; Yuko Okubo; Kenzo Takahashi; Teruki Yanagi; Daichi Hoshina; Hiroo Hata; Riichiro Abe; Taku Fujimura; Takeru Funakoshi; Koji Yoshino; Mamiko Masuzawa; Yasuyuki Amoh; Ryota Tanaka; Yasuhiro Fujisawa; Tetsuya Honda; Kenji Kabashima
Journal:  Oncoimmunology       Date:  2016-11-04       Impact factor: 8.110

3.  In situ synthesis of calcium phosphate-polycaprolactone nanocomposites with high ceramic volume fractions.

Authors:  C Makarov; I Gotman; X Jiang; S Fuchs; C J Kirkpatrick; E Y Gutmanas
Journal:  J Mater Sci Mater Med       Date:  2010-03-09       Impact factor: 3.896

4.  Generation of a murine hepatic angiosarcoma cell line and reproducible mouse tumor model.

Authors:  Sonja Rothweiler; Michael T Dill; Luigi Terracciano; Zuzanna Makowska; Luca Quagliata; Ruslan Hlushchuk; Valentin Djonov; Markus H Heim; David Semela
Journal:  Lab Invest       Date:  2014-11-24       Impact factor: 5.662

Review 5.  Extracellular Phosphate, Inflammation and Cytotoxicity.

Authors:  Toshimi Michigami; Miwa Yamazaki; Mohammed S Razzaque
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

6.  Identification of an aberrant cell line among human adipose tissue-derived stem cell isolates.

Authors:  Hongxiu Ning; Gang Liu; Guiting Lin; Maurice Garcia; Long-Cheng Li; Tom F Lue; Ching-Shwun Lin
Journal:  Differentiation       Date:  2008-10-21       Impact factor: 3.880

7.  Loss of autocrine endothelial-derived VEGF significantly reduces hemangiosarcoma development in conditional p53-deficient mice.

Authors:  Morvarid Farhang Ghahremani; Enrico Radaelli; Katharina Haigh; Sonia Bartunkova; Lieven Haenebalcke; Jean-Christophe Marine; Steven Goossens; Jody J Haigh
Journal:  Cell Cycle       Date:  2014-03-11       Impact factor: 4.534

8.  Immunohistochemical detection of sphingosine-1-phosphate receptor 1 in vascular and lymphatic endothelial cells.

Authors:  Takashi Akiyama; Yoshito Sadahira; Kiminori Matsubara; Masaharu Mori; Yasuyuki Igarashi
Journal:  J Mol Histol       Date:  2008-08-29       Impact factor: 2.611

9.  Constitutive phosphorylation of the mTORC2/Akt/4E-BP1 pathway in newly derived canine hemangiosarcoma cell lines.

Authors:  Atsuko Murai; Samah Abou Asa; Atsushi Kodama; Akihiro Hirata; Tokuma Yanai; Hiroki Sakai
Journal:  BMC Vet Res       Date:  2012-07-29       Impact factor: 2.741

10.  Establishment and characterization of a novel lymphangiosarcoma cell line (MO-LAS) compared with the hemangiosarcoma cell line (ISO-HAS).

Authors:  Mikio Masuzawa; Mamiko Masuzawa; Yuhko Hamada; Nobuko Arakawa; Mari Mori; Masako Ishii; Shigeo Nishiyama
Journal:  Cancer Med       Date:  2012-07-13       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.